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Purpose: Some forms of congenital muscular dystrophy are associated with cortical and retinal dysplasias. Protein O-
mannose N-acetylglucosaminyltransferase 1 (POMGnT1) knockout mice, one of the mouse models of muscular dystrophy,
exhibit a thinner retina with reduced density of retinal ganglion cells. This study is aimed to further characterize the
knockout retina, with special emphasis on the inner limiting membrane, the basement membrane of the retina.
Methods: Immunofluorescence staining and transmission electron microscopy were used to analyze the retinas. Atomic
force microscopy was performed on the inner limiting membrane preparations to examine their mechanical properties.
Results: The inner limiting membrane of the knockout mice exhibited frequent breaks with protrusions of the Müller glial
processes and ectopic placement of retinal ganglion cells into the vitreous humor. Disruptions in inner limiting membrane
integrity developmentally precede the cellular abnormalities. Regions of disrupted inner limiting membrane were also
associated with molecular abnormalities of Müller glia that included diminished presence of the integral membrane
proteins  Kir4.1  (an  inwardly  rectifying  potassium  channel)  and  aquaporin-4.  When  measured  with  atomic  force
microscopy, the POMGnT1 knockout mouse inner limiting membrane (ILM) exhibited significantly reduced Young’s
modulus and is therefore mechanically weaker than the ILM from controls.
Conclusions: Deficiency of POMGnT1-mediated glycosylation of dystroglycan is implicated in reduced stiffness of the
ILM. The weakened ILM results in the disruption of the membrane and subsequent reduction in retinal integrity.
Congenital muscular dystrophies (CMDs) with type II
lissencephaly  and  retinal  malformations  include  Walker–
Warburg  syndrome  (WWS),  muscle-eye-brain  disease
(MEB), Fukuyama congenital muscular dystrophy (FCMD),
and  congenital  muscular  dystrophy  1D  (MDC1D)  [1-13].
Many of these patients have mutations in genes encoding
glycosyltransferases  (or  putative  glycosyltransferases),
POMT1  (encoding  protein  O-mannosyltransferase  1,
POMT1) [14,15], POMT2 [16], POMGnT1 (encoding protein
O-mannose N-acetylglucosaminyltransferase 1, POMGnT1)
[17], Large [18], FCMD (encoding fukutin) [19,20] FKRP,
(encoding  fukutin-related  protein,  FKRP)  [21-23].  Ocular
abnormalities  of  muscle-eye-brain  disease  include  a
predisposition  to  glaucoma,  progressive  myopia,  juvenile
cataracts,  nystagmus,  uncontrollable  eye  movement,  and
retinal atrophy with reduced retinal function [1,9,11,24].
The mouse model of muscle-eye-brain (MEB) disease
exhibits similar phenotypes in the retina. POMGnT1 knockout
mice  have  a  thin  retina  with  reduced  density  of  retinal
ganglion  cells  [25].  Functionally,  the  knockout  retina  has
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reduced  electroretinogram  response  in  dark-adapted
conditions  [25].  Similar  phenotypes  exist  in  other  mouse
models of CMDs, the natural mutant Largemyd mice [26,27],
and chimeric fukutin knockout mice [28].
A common molecular phenotype in these CMDs is the
hypoglycosylation of α-dystroglycan, a glycoprotein heavily
substituted  by  O-linked  glycans,  particularly  O-linked
mannosyl  type,  for  example,
Siaα2,3Galβ1,4GlcNAcβ1,2Man-Ser/Thr  [29-31].  At  least
some  of  the  identified  CMD  genes  are  involved  in  the
synthesis of O-mannosyl glycans. POMT1 and POMT2 are
an  enzyme  complex  that  transfers  mannose  to  serine  or
threonine  residues  [32,33].  POMGnT1  transfers  N-
acetylglucosamine  to  O-linked  mannose  [17,34].  The
catalytic  functions  of  fukutin  and  Large  are  not  yet  fully
identified. Large is involved in phosphoryl glycosylation of
O-mannose  and  complex  N-  or  mucin  O-linked  N-
acetylgalactosaminyl glycans [35-37]. At the cell surface, α-
dystroglycan binds with high affinity to several extracellular
matrix  components,  including  laminin,  agrin,  perlecan,
neurexin,  and  pikachurin,  in  a  manner  dependent  on  its
carbohydrate conjugates [38-43]. α-Dystroglycan binds to the
transmembrane β-dystroglycan at the cell surface [44,45]. The
intracellular  domain  of  β-dystroglycan  interacts  with
cytoskeletal components, such as dystrophin and utrophin.
Molecular Vision 2010; 16:1415-1428 <http://www.molvis.org/molvis/v16/a155>
Received 25 March 2010 | Accepted 23 July 2010 | Published 28 July 2010
© 2010 Molecular Vision
1415Thus, α-dystroglycan and its glycoconjugates participate in an
important linkage between the extracellular matrix and the
cytoskeleton. Hypoglycosylation of α-dystroglycan leads to
loss of its binding activity to laminin, a major component of
the  extracellular  matrix  basement  membrane  [18,25,28,
46-49],  and  thus  would  negatively  affect  the  mechanical
linkage between the basement membrane and intracellular
cytoskeleton.
The basement membrane is a specialized extracellular
matrix that is mainly composed of laminins, collagen IV,
perlecan,  and  nidogen  [50,51].  Laminins  and  collagen
organize  this  matrix  via  polymerization  and  bind  to
nonpolymerizing molecules, such as perlecan. The retina has
two  specific  basement  membranes,  the  inner  limiting
membrane of the neural retina and Bruch’s membrane of the
pigmented epithelium. In this paper we describe biologic and
physical  effects  of  POMGnT1-deficiency  on  the  inner
limiting  membrane,  with  concomitant  effects  upon  some
retinal cell types.
METHODS
Animals: Protocols for animal usage were approved by the
Institutional Animal Care and Use Committee of the State
University of New York Upstate Medical University and were
in accordance with National Institutes of Health guidelines.
POMGnT1  knockout  mice  were  generated  from  a
POMGnT1-trapped  embryonic  stem  (ES)  cell  line  in  the
OmniBank  embryonic  stem  cell  gene-trap  library  in
collaboration with Lexicon Genetics Inc. (The Woodlands,
TX) [25]. For timed pregnancy, noon on the date of plug
observation was considered embryonic day (E)0.5. Date of
birth  was  considered  postnatal  day  (P)0.  A  total  of  eight
homozygous (−/−) fetal mice (two at E11.5, one at E13.5,
three at E15.5, and two at 17.5), 11 homozygous postnatal
mice (one at P0, one at P21, and nine adults) were used in this
study. Wild-type (+/+) and sometimes heterozygous (+/−)
littermates were used as controls.
Antibodies:  IIH6C4  (an  antibody  against  carbohydrate
epitope  of  α-dystroglycan),  anti-water-conducting  protein
aquaporin-4 (AQP-4), and anti-inwardly rectifying potassium
channel Kir4.1 were obtained from Millipore Corporation
(Billerica, MA). Anti-β-dystroglycan antibody (clone 7D11)
was obtained from Developmental Studies Hybridoma Bank
(University  of  Iowa,  Iowa  City,  IA).  Monoclonal  anti-
dystrophin  antibody  was  obtained  from  Millipore
Corporation.  A  polyclonal  anti-laminin-111  antibody  was
obtained  from  Sigma-Aldrich  (St.  Louis,  MO).  Antibody
against  cellular  retinaldehyde-binding  protein  (CRALBP)
was obtained from Abcam (Cambridge, MA).
Western blot analyses: The retinas were homogenized on ice
in Tris-buffer saline (TBS) containing 0.5% Triton X-100 and
a cocktail of protease inhibitors and centrifuged at 30,000× g
for 1 h at 4 °C. The supernatant was collected. Wheat germ
agglutinin (WGA)-agarose was added and incubated at 4 °C
overnight. Glycoproteins were eluted from the WGA-agarose
and separated on a 7% sodium dodecyl sulfate–PAGE gel. The
proteins were electrotransferred onto polyvinylidene fluoride
membrane filters. Filters were blocked by 2% BSA in TBS,
incubated  with  primary  antibody,  and  then  secondary
antibody conjugated with horse radish peroxidase. The results
were  visualized  with  an  enhanced  chemiluminescence
detection kit (Pierce, Rockford, IL). For the laminin overlay
assay on polyvinylidene fluoride membranes, all buffers used
contained 1 mM Ca2+ and Mg2+. The filter was incubated with
laminin (1 μg/ml) overnight at 4 °C, washed, and detected with
anti-laminin antibody as described above.
Immunostaining: Adult mice were killed by an overdose of
pentobarbital  injected  intraperitoneally  at  400  mg/kg
bodyweight, and the eyes were fixed by intracardial perfusion
of  4%  paraformaldehyde.  After  cryoprotection  with  30%
sucrose,  the  eyes  were  embedded  in  optimal  cutting
temperature  (OCT)  compound  in  cryomolds,  cryostat
sectioned in the coronal plane at 10 μm, and mounted on
Superfrost  plus  slides  (Fisher  Scientific,  Pittsburgh,  PA).
Primary  and  fluorescence  secondary  antibody  incubations
were performed as described previously [52,53]. Briefly, the
sections were blocked with 3% BSA (BSA) in phosphate
buffer (pH 7.4) for 1 h to reduced non-specific binding. Then
the sections were incubated with primary antibodies diluted
in 3% BSA overnight at 4 °C. Monoclonal antibodies against
AQP-4,  β-dystroglycan,  dystrophin,  CRALBP,  and  Kir4.1
were used at 1 to 200 dilution. Polyclonal antibody against
laminin-111 was used at 1 to 1,000 dilution. After washing
extensively with phosphate buffer containing 0.1% Triton
X-100,  the  sections  were  then  incubated  with  fluorescein
isothiocyanate- or rhodamine-isothiocyanate-conjugated goat
anti-mouse IgG or goat anti rabbit IgG at 1 to 400 dilution.
After washing with phosphate buffer containing 0.1% Triton
X-100, the sections were counterstained with DAPI (Sigma-
Aldrich, St. Louis, MO) to show nuclei. Some slides were
processed  without  incubation  with  primary  antibodies  as
controls. Fluorescence was visualized with a Zeiss Axioskop
upright fluorescence microscope.
Electron  microscopy:  Newborn  and  adult  animals  were
anesthetized  by  intraperitoneal  injection  of  pentobarbital
(400 mg/kg bodyweight). Deeply anesthetized animals were
then perfused with 3.7% glutaraldehyde. The eyes, including
some surrounding tissues, were then excised. The samples
were postfixed in 1% osmium tetroxide and stained en bloc
with 1.0% uranyl acetate, dehydrated, embedded in Poly/Bed
812 resin (Polysciences, Warrington, PA), and cut into thin
sections. The sections were stained with 2.0% uranyl acetate
and Reynold’s lead citrate (Polysciences). The samples were
observed, and digital photographs were taken with a Tecnai
T12 transmission electron microscope (FEI Company, Salem,
MA).
Molecular Vision 2010; 16:1415-1428 <http://www.molvis.org/molvis/v16/a155> © 2010 Molecular Vision
1416Preparation and atomic force microscopic analysis of the
inner  limiting  membrane:  Preparation,  atomic  force
microscopy  (AFM)  force  indentation  experiments,  and
calculation  of  elasticity  were  performed  as  published
elsewhere [54]. Briefly, retinas of P2 mice were spread onto
nitrocellulose  membrane  filters.  The  retina/filter  was  then
placed, vitreous side facing down, onto a polylysine-coated
glass slide. After removal of the filter and filter-bound retinal
tissue, the slides with the attached inner limiting membrane
(ILM) were washed extensively with 2% Triton X-100 to
remove  cellular  remnants.  The  ILM  samples  were
immunostained  for  laminin  to  localize  the  transparent
basement membranes (BMs) on the slides and then probed.
The imaging and force indentation experiments were done by
an MFP-3D AFM (Asylum Research, Santa Barbara, CA)
mounted  on  top  of  an  Olympus  IX-71  fluorescence
microscope (Olympus, Tokyo, Japan). For all experiments
100-mm long silicon-nitride cantilevers with pyramidal tips
(Veeco,  Inc.,  Santa  Barbara,  CA)  were  used  that  have  a
nominal  spring  constant  of  approximately  0.8  N/m.  The
elasticity was determined by the force-indentation method as
previously described. Comparison of the apparent Young’s
modulus between the knockouts and the wild-type controls
were analyzed by ANOVA (ANOVA).
RESULTS
Discontinuous  inner  limiting  membrane  in  POMGnT1
knockout mice: The retina of the POMGnT1 knockout mouse
was dysmorphic. We earlier reported this strain has a thinner
retina  and  reduced  density  of  retinal  ganglion  cells  [25].
Western blot analysis with IIH6C4 [41,45] (an antibody that
recognizes  the  functionally  glycosylated  form  of  α-
dystroglycan) was performed. As expected, α-dystroglycan
from POMGnT1 knockout mouse retina showed markedly
reduced immunoreactivity, indicating that glycosylation of α-
dystroglycan was affected (data not shown). To determine
whether POMGnT1 deficiency, and by extension the resultant
hypoglycosylation, affected dystroglycan expression in the
retina, we performed immunofluorescence staining with an
antibody  against  β-dystroglycan  (Figure  1,  green
fluorescence). The sections were also double stained with
anti-laminin  to  reveal  the  basement  membrane  (red
fluorescence).  In  wild-type  retinas,  strong  β-dystroglycan
expression  was  detected  at  the  inner  limiting  membrane
(asterisk in Figure 1A), blood vessels (arrowhead in Figure
1A), the outer plexiform layer (arrow in Figure 1A), and
Bruch’s  membrane  (open  squares  in  Figure  1A).  A  weak
expression of β-dystroglycan was also apparent in the inner
plexiform layer. Laminin expression was detected in wild-
type retinas at the inner limiting membrane (asterisk in Figure
1B), blood vessels (arrowhead in Figure 1B), and Bruch’s
membrane  (open  squares  in  Figure  1B).  In  contrast  to
dystroglycan, laminin expression was not detected in the outer
or inner plexiform layers (with the exception of blood vessels
in these two layers). In POMGnT1 knockout retinas, the inner
limiting  membrane  appeared  discontinuous  with  frequent
breaks (arrows in Figure 1D,E) for both β-dystroglycan and
laminin immunostaining. The immunofluorescence patterns
for β-dystroglycan and laminin in other retinal regions were
similar to that of the wild-type retinas (compare Figure 1D–F
with Figure 1A–C). We also examined the expression pattern
of dystrophin, an intracellular cytoskeletal protein associated
with  β-dystroglycan.  Its  expression  pattern  at  the  outer
plexiform layer and blood vessels in knockout and wild-type
retinas was similar to β-dystroglycan (DG; not shown). Thus,
despite reduced glycosylation, dystroglycan distribution in
the  knockout  retina  was  not  grossly  affected,  with  the
exception of frequent breaks in the laminin and dystroglycan
labeling of the inner limiting membrane.
Inner limiting membrane disruptions and ectopia of retinal
ganglion cells in POMGnT1 knockout mice: Loss of binding
activity to extracellular matrix molecules may affect inner
limiting  membrane  integrity  because  dystroglycan  in  the
endfeet of Müller glia may serve as a receptor for basement
membrane  assembly.  Further,  frequent  breaks  in  laminin
staining suggest the possibility of inner limiting membrane
disruptions.  When  analyzed  by  electron  microscopy,
numerous disruptions in the inner limiting membrane were
confirmed for the POMGnT1 knockout retina (e.g., region
between the arrows in Figure 2B). By contrast, the wild-type
inner  limiting  membrane  was  continuous,  displaying  no
breaks (arrowheads in Figure 2A). In the knockout mice,
Müller glia endfeet protruded into the vitreous at sites of inner
limiting membrane disruption (Figure 2B). In contrast to the
inner limiting membrane, Bruch’s membrane in the knockout
mice  was  not  affected  (arrowheads  in  Figure  2D),  being
similar to the wild type (Figure 2C) in displaying no apparent
breaks or nearby cellular disruptions.
Along with protrusion of Müller glial processes into the
vitreous,  ectopia  of  some  retinal  ganglion  cells  into  the
vitreous  was  also  frequently  observed  at  the  location  of
breached inner limiting membrane (dark circles in Figure 3B).
Components of the inner plexiform layer in knockout retinas
were also occasionally observed in the vitreous (dark square
in Figure 3B). The ectopia of cellular processes from the retina
into  the  vitreous  was  also  apparent  on  scanning  electron
microscopy images of retinal whole mounts (Figure 3D). By
contrast, the wild-type retina always showed a smooth inner
limiting  membrane  surface  with  no  ectopic  cells  on  top
(Figure 3A,C).
Morphological and molecular changes in Müller glia: To
examine further the morphology of Müller glia, we screened
sections with an antibody for CRALBP, a Müller glia marker
(Figure 4A,B). The morphological changes in Müller glia
endfeet  associated  with  POMGnT1  deficiency  described
above were also evident with immunofluorescence detection
of anti-CRALBP. While the Müller glia endfeet in wild-type
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1417mice  formed  a  continuous  lining  at  the  inner  limiting
membrane (arrowheads in Figure 4A), the knockout Müller
glia endfeet were observed to have frequent protrusions into
the vitreous (arrows in Figure 4B).
Müller glia in mouse retinas express integral membrane
proteins,  including  the  potassium  channel  Kir4.1  and  the
water channel AQP-4, at high levels. To examine whether
localization of Kir4.1 and AQP-4 is affected in the knockout
retina, we separately screened retinal sections with antibodies
Figure  1.  Dystroglycan  distribution  at  the  Müller  glia  endfeet  and  inner  limiting  membrane  are  disrupted  in  protein  O-mannose  N-
acetylglucosaminyltransferase 1 (POMGnT1) knockout retina. Adult retinal sections were double stained with anti-β-dystroglycan (green
fluorescence) and anti-laminin (red fluorescence). Wild type (A-C) and knockout (D-F) retinas were immunostained with anti β-dystroglycan
(A, D) and laminin (B, E). All sections were counterstained with 4',6-diamidino-2-phenylindole to show nuclei. Merged image of A and B is
shown in C. Merged image of D and E is shown in F. Note β-dystroglycan and laminin staining at the inner limiting membrane had breaks
(arrows in D and E), indicating a lack of Müller glia endfeet and inner limiting membrane at these locations. Abbreviations: DG represents
dystroglycan; ILM represents inner limiting membrane; INL represents inner nuclear layer; IPL represents inner plexiform layer; ONL
represents outer nuclear layer; OPL represents outer plexiform layer, DAPI represents 4',6-diamidino-2-phenylindole; +/+ represents wild
type; −/− represents homozygous knockout. Scale bar in F is equal to 50 μm.
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1418against Kir4.1 and AQP-4. In the wild-type retina, anti-Kir4.1
labeled the entire radial processes with strong labeling of the
Müller glia endfeet at the inner limiting membrane (arrows in
Figure  4C).  In  addition,  blood  vessels  were  also  labeled
(arrowheads in Figure 4C). In POMGnT1 knockout retina,
although  the  Müller  glia  processes  and  blood  vessels  are
labeled similarly to the wild type, the endfeet labeling was less
robust,  being  characterized  by  particularly  weak,  if  not
altogether absent, labeling at regions with a disrupted inner
limiting membrane (asterisks in Figure 4D). Altered patterns
of AQP-4 distribution were also associated with POMGnT1
deficiency, with the knockout mice displaying reduced levels
of  AQP-4  at  the  inner  plexiform  layer  (IPL)  and  outer
plexiform layer (OPL). Like Kir4.1, there was also substantial
reduction of AQP-4 at regions indicative of inner limiting
membrane  disruption  (cf.  Figure  4E  and  Figure  5F).
Localization of the integral membrane proteins Kir4.1 and
AQP-4 at Müller glia endfeet was thus disrupted in response
to POMGnT1 knockout.
Breaches in the developing inner limiting membrane precedes
ectopia of Müller glia processes and retinal ganglion cells:
To explore the integrity of the inner limiting membrane during
development, we performed electron microscopic analysis of
the retina at several developmental stages. The inner limiting
membrane  at  E11.5  in  the  knockout  mouse  (Figure  5B)
showed the same undisrupted continuity as was seen in the
wild-type mouse (Figure 5A). Breaks in the inner limiting
membrane were observed as early as E13.5 (Figure 5D) and
in all other older ages analyzed, including E15.5 (Figure 5F),
E17.5, P0, P21, and adult. At earlier ages (E13.5 and 15.5),
breaks  at  the  inner  limiting  membrane  were  sometimes
observed with (dark square in Figure 6A) or without (Figure
5D,F)  associated  ectopia  of  the  glial  processes  into  the
vitreous.
At later ages (E17.5 and onward, see Figure 6B–D), all
observed breaks were associated with protrusion of cellular
processes from the retina into the vitreous. Ectopia of retinal
ganglion cells was observed as early as E17.5 and remained
evident  from  P0  through  adult  (indicated  by  dark  circle).
These  results  suggest  that  breaks  in  the  inner  limiting
membrane associated with POMGnT1 deficiency temporally
precedes, and thus could be the causative factor of, atypical
Figure 2. Disruptions of the inner limiting membrane in protein O-mannose N-acetylglucosaminyltransferase 1 (POMGnT1) knockout retina.
Transmission electron microscopy was carried for the adult retinas. Micrographs of transmission electron microscopy of wild type (A, C) and
knockout (B, D) retinas are shown. Note that the wild-type inner limiting membrane was continuous (arrowheads in A). Knockout inner
limiting membrane was discontinuous (arrows in B) with protrusion of Müller glial processes into the vitreous humor. The knockout Bruch’s
membrane (arrowheads in D) was normal. The scale bar in B is equal to 500 nm for A and B. The scale bar in D is equal to 500 nm for C and
D. +/+ represents wild type; −/− represents homozygous knockout.
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1419protrusion of cell processes and retinal ganglion cells into the
vitreous.
Reduced  stiffness  of  the  inner  limiting  membrane:  To
determine  whether  the  biomechanical  properties  of  the
knockout inner limiting membrane is changed, we isolated the
inner  limiting  membrane  from  POMGnT1  knockout  and
Largemyd mice since Largemyd mice also exhibit disruptions of
the inner limiting membrane [27]. When stained with anti-
laminin, the flatmounted inner limiting membrane from the
wild  type  showed  a  continuous  undisrupted
immunofluorescence  (Figure  7A).  By  contrast,  the  inner
limiting membranes of POMGnT1 knockout and Largemyd
mice exhibited many holes (Figure 7B,C). These holes are
caused by the disruptions in the inner limiting membrane, as
Figure 3. Protein O-mannose N-acetylglucosaminyltransferase 1 knockout retinas exhibit ectopia of retinal ganglion cells. Transmission and
scanning electron microscopy was performed for the adult retina. Transmission electromicroscopic micrographs (A, B) and scanning electron
microscopic micrographs (C, D) are shown. (A, C) show the wild type retinas. (B, D) show the knockout retinas. Note the presence of ectopic
retinal ganglion cells (dark circles) and inner plexiform layer components (dark square). Asterisks indicate the location of the inner limiting
membrane. The scale bar in A is equal to 2 μm. The scale bar in B is equal to 10 μm. The scale bar in D is equal to 10 μm for C and D. +/+
represents wild type; −/− represents homozygous knockout.
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1420described  above  (Figure  2,  Figure  3,  and  Figure  6).  To
measure the Young’s modulus, force indentation experiments
were performed on four inner limiting membrane preparations
from each genotype, using AFM (Table 1). Figure 7D,E show
representative curves of AFM loading force versus the z-piezo
position for POMGnT1 knockout and Largemyd inner limiting
membranes. These measurements showed that the apparent
Young’s modulus (Figure 7F) for the wild-type inner limiting
Figure 4. Morphological changes were
observed in the Müller glia of protein O-
mannose  N-
acetylglucosaminyltransferase  1
knockout retinas. Adult retinal sections
were  immunostained  with  antibodies
against  cellular  retinaldehyde-binding
protein  (CRALBP;  A  and  B),  Kir4.1
(C and D), and aquaporin-4 (AQP-4; E
and  F).  Fluorescence  micrographs
shown in A, C, and E are from wild type
retinas  and  fluorescence  micrographs
shown in B, D, and F are from knockout
retinas. Note the protrusion of Müller
glia endfeet intro the vitreous (arrows in
B)  and  reduced  levels  of  Kir4.1  and
AQP-4 at sites lacking the inner limiting
membrane (asterisks in D and F). The
scale  bar  in  F  is  equal  to  100  μm.
Abbreviations:  AQP-4  represents
aquaporin-4;  CRALBP  represents
cellular retinaldehyde-binding protein;
DAPI  represents  4',6-diamidino-2-
phenylindole;  INL  represent  inner
nuclear  layer;  ILM  represents  inner
limiting  membrane;  IPL  represents
inner plexiform layer; ONL represents
outer  nuclear  layer;  OPL  represents
outer plexiform layer.
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1421membrane was 4.08±1.19 MPa (mean±standard deviation;
n=4). The Young’s moduli of the inner limiting membranes
from  POMGnT1  knockout  and  Largemyd  mice  were
significantly  reduced  (2.82±1.22  and  1.68±0.73  MPa,
respectively; p<0.01, ANOVA; n=4 each). AFM thickness
measurement did not reveal significant differences between
the knockouts and the wild type (data not shown). These
results indicated that POMGnT1 knockout and Largemyd inner
limiting membranes exhibited reduced stiffness.
DISCUSSION
The POMGnT1 knockout mice were previously reported to
exhibit  a  thinner  retina  with  reduced  density  of  retinal
ganglion cells [25]. In this paper, we report that some ganglion
cells were located ectopically on the vitreous side of the inner
limiting  membrane.  The  retinal  ganglion  cell  ectopia  is  a
developmental event caused by physical breaches in the inner
limiting membrane that occur starting at E13.5. Interestingly,
the basement membrane of the pigmented epithelium, the
Bruch’s membrane, is not affected by POMGnT1 deficiency.
Thus,  with  respect  to  basement  membrane  biology  in  the
retina,  POMGnT1-mediated  glycosylation  events  are
apparently selectively required for maintaining the structural
integrity of the inner limiting membrane.
Ectopia of nerve cells through the basement membrane
into the mesenchymal tissue also occurs in the cerebral cortex
and the cerebellum of POMGnT1 knockout mice [53,55].
Does the breached basement membrane permit the movement
of  cells  to  ectopic  locations?  Or  do  the  migrating  cells/
processes penetrate the intact basement membrane, causing
the breaches in the basement membrane? At all developmental
stages analyzed for the cerebral cortex and the cerebellum,
disrupted basement membrane was always associated with
protrusion  of  radial  and  Bergman  glia,  respectively,  and
associated  with  ectopia  of  cerebral  cortical  neurons  and
cerebellar granule cells [53]. It was not possible to discern the
causal  relationship  of  the  breaches  in  the  pial  basement
membrane and the protrusion of cell processes and migrating
neurons. The current investigation of retinas in POMGnT1-
deficient  mice,  however,  indicated  that  at  their  earliest
manifestations, breaches in the inner limiting membrane were
not  always  associated  with  protrusion  of  cells  or  cellular
processes. Such associations were invariably observed at later
developmental points. These findings are consistent with the
model  that  neural  ectopias  follow  breached  basement
membranes.
A broken inner limiting membrane is also observed in
some other animal models. In the natural mutant of Large,
Largemyd  mice,  a  gene  involved  in  glycosylation  of  α-
dystroglycan  [27],  breached  inner  limiting  membrane  and
ectopia of retinal ganglion cells were observed. Mutations in
the laminin β2 chain, a component of the basement membrane,
cause congenital nephritic syndrome with abnormal retina
[56]. Mouse knockout of β2 laminin also exhibits broken inner
limiting  membrane  along  with  altered  morphology  of
photoreceptor outer segments, synaptic disruption in the outer
plexiform layer (OPL), and disoriented Müller glia [57-59].
Earlier studies showed that survival of retinal ganglion cells
is dependent on the integrity of the inner limiting membrane
[60]. Thus, the reduced retinal ganglion cell density found in
POMGnT1  knockout  mice  may  be  directly  related  to  the
disruptions in the inner limiting membrane.
Figure  5.  Inner  limiting  membrane
disruptions  during  early  eye
development in protein O-mannose N-
acetylglucosaminyltransferase  1
(POMGnT1) knockout mice. Electron
microscopic analysis was performed on
the developing retinas at embryonic day
11.5 (A and B), embryonic day 13.5 (C
and D), and embryonic day 15.5 (E and
F).  A,  C,  and  E  are  from  wildtype
retinas. B, D, and F are from knockout
retinas. Note the broken inner limiting
membrane at E13.5 (arrow in D) and the
absence of the inner limiting membrane
at E15.5 (asterisks in F) in POMGnT1
knockout mouse retina. The scale bar in
D is equal to 500 nm. +/+ represents wild
type;  −/−  represents  homozygous
knockout.
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1422Although it is presumed that abolished binding between
the hypoglycosylated α-dystroglycan and the laminin of the
basement  membrane  is  involved  in  the  observed  retinal
abnormalities,  the  mechanisms  that  cause  basement
membrane breaches in various congenital muscular dystrophy
models are not clear. Through analysis with AFM, we found
that the inner limiting membranes of POMGnT1 knockout and
Largemyd  mice  have  significantly  reduced  stiffness.  Thus,
reduced physical strength of the inner limiting membrane is
at  least  a  contributing  factor  in  their  disruptions.  Major
components of the inner limiting membrane are produced by
the  lens  and  ciliary  body,  secreted  into  the  vitreous,  and
assembled  at  the  retinal  inner  surface  [61-63].  Because
extracellular  matrix  receptors,  particularly  integrin  and
dystroglycan, at the cell surface are instrumental in assembly
of the basement membrane [64], reduced binding to laminin
might  result  in  the  assembly  of  a  defective  basement
membrane that is mechanically weaker.
The key molecule mediating the functions of congenital
muscular dystrophy genes is believed to be α-dystroglycan.
Dystroglycans  (α  and  β)  are  required  for  normal  retinal
development,  as  morpholino-mediated  knockdown  of
dystroglycan  expression  in  the  developing  Xenopus  eye
results in severe lamination defects [65]. In the mammalian
retina, dystroglycan is highly expressed by photoreceptors at
the presynaptic terminal in the outer plexiform layer and by
Müller  glia  cell  endfeet  at  the  inner  limiting  membrane
[66-73]. Knockout of dystroglycan in the developing mouse
embryo  results  in  a  thinner  retina  with  a  disrupted  inner
limiting membrane [74]. High expression of dystroglycan in
the presynaptic terminals of photoreceptors and inner limiting
membrane  suggests  that  glycosylation  defects  of  α-
dystroglycan may affect these two sites of the retina. Indeed,
as demonstrated in the current study, a primary site of defect
in POMGnT1 knockout retina is the inner limiting membrane
where breaches resulted in ectopia of retinal ganglion cells
and Müller glia processes.
It is of some interest to compare the phenotypes between
POMGnT1 knockout and Largemyd mice. Both inner limiting
membranes are breached with reduced stiffness, resulting in
ectopia of retinal ganglion cells. While the majority of the
laminin staining at the inner limiting membrane of Largemyd
retina is lost, according to a previous report [75], abnormal
laminin  staining  in  POMGnT1  knockout  mice  was  only
Figure  6.  Cellular  ectopia  into  the
vitreous  humor  through  the  breached
inner limiting membrane was observed
at all stages after embryonic day 13.5.
Protein  O-mannose  N-
acetylglucosaminyltransferase  1
(POMGnT1) knockout retinas at E13.5
(A), E17.5 (B), P0 (C), and P21 (D)
were analyzed by electron microscopy.
Note  the  protrusion  of  radial  glial
processes (dark square in A) and ectopia
of retinal ganglion cells (dark circles in
B–D). Asterisks indicate the location of
the  inner  limiting  membrane.
Abbreviations: E represents embryonic
day;  P  represents  postnatal  day.  The
scale bars in A–C are equal to 500 nm.
The scale bar in D is equal to 2 μm.
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1423observed  at  sites  where  the  basement  membrane  was
apparently  disrupted.  This  could  be  due  to  technical
differences in the antibodies used for staining. We therefore
stained  Largemyd  mouse  retinal  sections  with  anti-laminin
antibody. Similar to POMGnT1 knockout mice, significant
laminin immunostaining at the inner limiting membrane was
observed  in  Largemyd  mouse  retina.  However,  laminin
immunostaining was notably absent in areas where the inner
limiting membrane was apparently disrupted (see arrow in
Figure 8B). In areas free of breach, the laminin staining of the
inner  limiting  membrane  was  continuous  in  both  mouse
models.
Laminin interaction with the dystroglycan complex is
known to regulate the distribution of Kir4.1 and AQP-4 [76,
77]. In normal retina, both of these membrane integral proteins
are present throughout the radial extent of Müller glial but are
present at particularly high levels at the endfeet. Astrocytic
endfeet at the blood vessels also highly express both of these
channel  proteins.  As  expected,  their  localization  in
POMGnT1 knockout retina is dependent on the integrity of
the  inner  limiting  membrane.  In  regions  where  the  inner
limiting membrane is normal, the presence of both channels
remains comparable to the controls. However, at sites of inner
limiting  membrane  breaches,  their  levels  are  substantially
reduced.  These  results  suggest  that  the  mechanism  of
Figure 7. Inner limiting membranes of
protein  O-mannose  N-
acetylglucosaminyltransferase  1
(POMGnT1)  knockout  and  Largemyd
mice  exhibit  reduced  elasticity.
Flatmounted inner limiting membranes
from postnatal day 2 (P2) newborn mice
were immunostained with anti-laminin.
AFM  indentation  experiments  were
performed  to  determine  the  Young’s
modulus.  Micrographs  of  laminin
immunofluorescence  staining  of  wild
type  (A),  protein  O-mannose  N-
acetylglucosaminyltransferase  1
knockout (B) and Largemyd mice (C) are
shown.  Note  that  the  mutant  inner
limiting membranes showed many holes
(B and C). D and E are representative
force  displacement  curves  for
indentation  experiments  on  the  inner
limiting  membranes  of  protein  O-
mannose  N-
acetylglucosaminyltransferase  1
knockout and Largemyd mice. Apparent
Young’s modulus measurements from
inner limiting membranes isolated from
4 mice for each genotype are shown in
F.  The  bars  represent  means  with
standard deviations (p<0.01, ANOVA).
When  compared  to  the  controls,
significantly reduced Young’s modulus
was  observed  for  both  POMGnT1
knockout  (p<0.01)  and  Largemyd
(p<0.01)  inner  limiting  membranes
(post hoc Student’s t-test). Asterisks in
F  indicate  p<0.01.  These  results
indicated  that  the  inner  limiting
membranes  of  protein  O-mannose  N-
acetylglucosaminyltransferase  1
knockout and Largemyd mice exhibited
reduced elasticity compared to the wild
type. MPa represents megapascal. nN
represents nanonewton. The scale bar in
C is equal to 25 μm.
Molecular Vision 2010; 16:1415-1428 <http://www.molvis.org/molvis/v16/a155> © 2010 Molecular Vision
1424POMGnT1-dependent  disruptions  in  retinal  organization
associated  with  the  inner  limiting  membrane  involves
hypoglycosylation of the dystroglycan/laminin complex.
Interestingly, immunofluorescence labeling revealed that
dystroglycan  distribution  in  the  outer  plexiform  layer  of
POMGnT1  knockout  mice  remains  largely  normal.
Nevertheless,  the  defective  electroretinogram  b-wave  of
POMGnT1  knockout  mice  suggests  that  O-mannosyl
glycosylation may play a role in synaptic transmission in the
outer retina [25]. Interpretation of this result, however, is
complicated  by  anatomic  defects  observed  in  the  null
knockout  mice.  Conditional  knockout  mice,  where  O-
mannosyl  glycosylation  can  be  knocked  out  with
(presumably) a minimum of developmental malformations,
will enable an improved understanding of how POMGnT1
and  O-mannosyl  glycosylation  contribute  to  retinal
development, structure, and function.
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